• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

LeMaitre Vascular (LMAT)

Common Shares
Sell: $86.50|Buy: $88.00|Change: 0.50 (-0.55%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Address

63 Second Avenue
Burlington
MA
USA
01803

Telephone

+1 781 221-2266

Website

https://www.lemaitre.com

Sector 

Healthcare

Forecast key dates

NameKey Date
LeMaitre Vascular Inc First Quarter Earnings Conference Call for 20262026-05-01T17:00:00
LeMaitre Vascular Inc First Quarter Earnings Results for 20262026-05-01T00:00:00
LeMaitre Vascular Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T17:00:00
LeMaitre Vascular Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
LeMaitre Vascular Inc Annual Report for 20252026-02-27T00:00:00
LeMaitre Vascular Inc Third Quarter Earnings Conference Call for 20252025-10-31T17:00:00
LeMaitre Vascular Inc Third Quarter Earnings Results for 20252025-10-31T00:00:00
LeMaitre Vascular Inc Second Quarter Earnings Conference Call for 20252025-08-01T17:00:00
LeMaitre Vascular Inc Second Quarter Earnings Results for 20252025-08-01T00:00:00
LeMaitre Vascular Inc Annual General Meeting for 20252025-06-03T10:00:00
LeMaitre Vascular Inc First Quarter Earnings Conference Call for 20252025-05-01T17:00:00
LeMaitre Vascular Inc First Quarter Earnings Result for 20252025-05-01T00:00:00

Previous key dates

NameKey Date
LeMaitre Vascular Inc First Quarter Earnings Conference Call for 20252025-05-01T17:00:00
LeMaitre Vascular Inc First Quarter Earnings Result for 20252025-05-01T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-08T15:45:00
Oppenheimer 35(th) Annual Healthcare MedTech & Services Conference2025-03-20T10:00:00
KeyBanc Healthcare Forum2025-03-19T13:30:00
37(th) Annual ROTH Conference2025-03-17T16:00:00
LeMaitre Vascular Inc Annual Report for 20242025-02-28T00:00:00
LeMaitre Vascular Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T17:00:00
LeMaitre Vascular Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
LeMaitre Vascular, Inc. announced Wolfe Research Healthcare Conference 20242024-11-20T14:00:00
LeMaitre Vascular, Inc. announced Stifel's 2024 Healthcare Conference2024-11-19T13:50:00
LeMaitre Vascular Inc announced today that management will be participating in the UBS Global Healthcare Conference2024-11-13T07:15:00
LeMaitre Vascular Inc Third Quarter Earnings Conference Call for 20242024-10-31T17:00:00
LeMaitre Vascular Inc Third Quarter Earnings Result for 20242024-10-31T00:00:00
Cantor Fitzgerald 2024 Global Healthcare Conference2024-09-19T08:00:00
Barrington Research Fall Investment Conference (Virtual)2024-09-12T00:00:00
Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-04T17:35:00
LeMaitre Vascular Inc Second Quarter Earnings Conference Call for 20242024-08-01T17:00:00
LeMaitre Vascular Inc Second Quarter Earnings Result for 20242024-08-01T00:00:00
LeMaitre the Jefferies Global Healthcare Conference 20242024-06-06T11:00:00
LeMaitre Vascular Inc Annual General Meeting for 20242024-06-03T10:00:00
LeMaitre Vascular Inc First Quarter Earnings Conference Call for 20242024-05-02T17:00:00
LeMaitre Vascular Inc First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.